Comparison of Norepinehrine Versus Phenylepherine Infusion for Prevention of Post-spinal Hypotension

Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age60-100
SponsorSohag University

About this trial

This prospective randomized double-blinded clinical trial aims to compare the efficacy and hemodynamic effects of prophylactic norepinephrine infusion versus phenylephrine infusion for prevention of spinal anesthesia-induced hypotension in elderly patients undergoing elective orthopedic hip surgery under subarachnoid block. Sixty-two patients aged 60 years or older will be randomly assigned into two equal groups to receive either norepinephrine infusion (8 µg/min) or phenylephrine infusion (100 µg/min) immediately after spinal anesthesia. The primary outcome is the mean heart rate during vasopressor infusion, while secondary outcomes include incidence of hypotension, severe hypotension, bradycardia, reactive hypertension, intraoperative fluid requirements, blood loss, transfusion requirements, and postoperative nausea and vomiting. Hemodynamic parameters will be monitored throughout surgery to evaluate the safety and effectiveness of both vasopressor strategies.

Eligibility criteria

Qualifiers

Age 60 years or older.

ASA physical status I-III.

Scheduled for elective hip surgery under subarachnoid block.

Willing to provide written informed consent.

Disqualifiers

Patient refusal.

Contraindications to subarachnoid block.

Severe cardiac disease.

Uncontrolled hypertension.

Trial design

Treatments tested in this trial

  • Norepinephrine
  • Phenylephrine

Treatment groups

62 Participants
are divided into 2 treatment groups

Sponsors and collaborators